Okas M. Novel Immunothrapeutical strategies in allogeneic hematopoietic stem cell transplantation [dissertation]. Sweden : Karolinska Institute; 2010. p. 9.
Thomas ED. A history of hematopoietic cell transplantation. Br J Haematol 1999; 105(2): 330-9.
Gluckman E. A brief History of Haematopoietic Stem Cell Transplantation. Eurocords documents 2011; Chapter 1. p. 1-4. Available from: http://www.eurocord-ed.org/download_docs_embed/_PARTNERS_FOLDER_/chapter1gluckmaneshebmt2012.pdf.
Baldomero H, Passweg J. Hematopoetic Stem Cell Transplantation In Europe: Data and trends in 2011. EBMT Annual Report 2012; 12: 10.
Apperley J, Keating A. Stem cell transplant organizations. In: Apperley J, Carreras E, Gluckman E, Masszi T. EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation. Switzerland: EMBT; 2012. p. 19-33.
World Marrow Donor Association. WMDA International Standards for Unrelated Hematopoietic Stem Cell Donor Registries; 2012. Available from: http://www.worldmarrow.org/fileadmin/Committees/STDC/20120101-STDC-WMDA_Standards.pdf.
Valcárcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, et al. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biol Blood Marrow Transplant 2011; 17(5): 640-8.
Bergstrom TC, Garratt R, Sheehan-Connor D. One Chance in a Million: Altruism and the Bone Marrow Registry. American Economic Review 2007; 99(4): 1-41.
Dickinson AM. Non-HLA immunogenetics and role in transplant outcome. In: EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation; 2012. p. 79-91.
Shaiegan M. Stem cell therapy and research status in Iran: at A glance. Iranian Journal of Blood and Cancer 2010; 2(3): 99-100.
Shaiegan M, Yari F, Abolghasemi H, Bagheri N, Paridar M , Heidari A et al. Allele Frequencies of HLA-A, B and DRB1 among People of Fars Ethnicity Living in Tehran. Iranian Journal of Blood and Cancer 2011; 4: 55-9.
Shaiegan M, Abolghasemi H, Yari F, Paridar M, Maghsudlu M, Amini Kafiabad S, et al. Comparison of Human Leukocyte Antigen Frequency in Iranian unrelated Stem cell donors during 2011-2012. Sci J Iran Blood Transfus Organ 2013; 10(3): 267- 81.
[Article in Farsi]
Abroun S. Cord Blood Banks: From the inception. Sci J Blood Transfus Organ 2014; ahead of print. [Article in Farsi]
Hamidieh AA. Stem cell donation: Barrier to incurable diseases. Iran Newspaper (2012 July 1); p. 14. [Farsi]
van Rood. J. Feature article: Global medicine Past, Present and Future Challenges. EBMT Annual Report 2012; 12: 8-9.
Review Article
Sci J Iran Blood Transfus Organ 2014; 11(2): 164-176
Unrelated stem cell donor registries in the world and Iran
Shaiegan M.1, Zolfaghari Anaraki S.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract Background and Objectives
It is more than 5 decades that hematopoietic stem cell transplantation (HSCT) has been used for treatment of hematologic malignancies, metabolic disordes, and immunodeficiencies. (HLA)-matched HSCT is commonly the preferred type of transplantation, with HLA-matched sibling donors usually the first choice. If there is no related HLA-matched donor, unrelated matched donors are considered.
Materials and Methods
The present article shows the importance of unrelated stem cell donor registries, related regulations and policies, HSCT history, the importance of donor-recipient HLA matching to GVHD inhibition, several donor selection measures, establishment requirements of such registries in the world and Iran, using 29 different references in order to introduce these centers to interested researchers.
Results
These Registries rely on positive feelings of unrelated donors to altruistic donation to save patients. Registries from different countries joined and established world and international donor associations and groups to facilitate finding a suitable donor and improve the HSCT outcomes from unrelated donors.
Conclusions
Huge progress has been made since the first HSCT to save many patients indebted to the efforts of a few pioneers, group collaborations, and international exchanges of stem cell practiced by international organizations which follow definite standards.
Correspondence: Shaiegan M., PhD of Immunology. Associate Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 88601564; Fax: (+9821) 88601599
E-mail: M.Shaiegan@ibto.ir
Shaiegan M, Zolgaghari Anaraki S. Unrelated stem cell donor registries in the world and Iran. Sci J Iran Blood Transfus Organ 2014; 11 (2) :164-176 URL: http://bloodjournal.ir/article-1-786-en.html